Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) prevalence by anatomical site and year
| Total n=2546 | March–September 2019 n=1554 | March–September 2021 n=992 | P value* | |||||||||
| NG only | CT only | NG and CT | NG only | CT only | NG and CT | NG only | CT only | NG and CT | NG only | CT only | NG and CT | |
| Rectal | 117 (4.60) | 157 (6.17) | 27 (1.06) | 56 (3.60) | 93 (5.98) | 17 (1.09) | 61 (6.15) | 64 (6.45) | 10 (1.01) | <0.01* | <0.01* | 0.83 |
| Pharyngeal | 116 (4.56) | 29 (1.14) | 4 (0.16) | 67 (4.31) | 19 (1.22) | 3 (0.19) | 49 (4.94) | 10 (1.01) | 1 (0.10) | <0.01* | <0.01* | 0.57 |
| Urethral | 27 (1.06) | 63 (2.47) | 5 (0.20) | 9 (0.58) | 31 (1.99) | 1 (0.06) | 18 (1.81) | 32 (3.23) | 4 (0.40) | <0.01* | <0.01* | 0.06 |
| Total unique | 194 (7.62) | 221 (8.68) | 39 (1.53) | 102 (6.56) | 128 (8.24) | 23 (1.48) | 92 (9.27) | 93 (9.38) | 16 (1.61) | 0.02* | 0.32 | 0.79 |
| Total with CT or NG | 376 (14.77) | 207 (13.32) | 169 (17.04) | 0.01* | ||||||||
*P values were calculated using χ2 tests and are statistically significant at the 0.05 level.